IMP: Approval of the selection of audit firm for the 2025 financial statements
IMP: Approval of the selection of audit firm for the 2025 financial statements
Approval of the selection of audit firm for the 2025 financial statements of Imexpharm Corporation as follows:
Attached Files: |
20250605 - IMP - Approval of the selection of audit firm for the 2025 financial statements.pdf |
HOSE